Two-year post-treatment outcomes following peanut oral immunotherapy in the Probiotic and Peanut Oral Immunotherapy-003 Long-Term (PPOIT-003LT) study.
Paxton LokeXiaofang WangMelanie LloydSarah E AshleyAdriana C LozinskyMichael GoldMichael D O'SullivanPatrick QuinnMarnie RobinsonAudrey Dunn GalvinFrancesca Orsininull nullMimi L K TangPublished in: Allergy (2024)
By 2-years post-treatment, remission participants reported fewer reactions, less severe reactions and greater HRQOL improvement compared with DWR and allergic participants, indicating that remission is the patient-preferred treatment outcome over desensitization or remaining allergic.